Organogenesis Inc., a developer of human tissue and organequivalents, has filed for a public offering of 1.25 millionshares of common stock. If the offering is completed, theCanton, Mass., company will have about 8 million sharesoutstanding. The offering will be managed by Gerard KlauerMattison & Co. Inc. Overallotment options haven't beendetermined.
The stock (AMEX:ORG) closed unchanged Tuesday at $19.88.
(c) 1997 American Health Consultants. All rights reserved.